StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Talk of billion dollar buy out is crazy

<< Previous

Bullboard Posts

Next >>

Comment by Thisguyiscoolon Apr 01, 2021 9:06am

107 Views

Post# 32921483

RE:RE:RE:RE:Talk of billion dollar buy out is crazy

Mykndrsn wrote: I would think someone with 400,000 shares would have a better understanding of the value Aristotle represents not today but down the road. That's the basis for a buyout.

Hey, question for the super smart guys that understand how buy outs work... where is my $44/share?

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing